FindTrial
Sign In

Studying Ways to Prevent Chemotherapy-Related Nausea and Vomiting in Cancer Patients at a Hospital

Clinical Assessment of Preventive Strategies for Chemotherapy Induced Nausea Vomiting in Cancer Patients at a Tertiary Care Teaching Hospital: A Prospective Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096586
Enrollment
150
Registered
2025-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D49-D49- Neoplasms of unspecified behavior

Interventions

Intervention1: Pharmacist Intervention: Patient will receive Patient Information Leaflet, Patient Education videos, Mobile Application, Patient Counselling during data collection until follow up at

Sponsors

KLE College of Pharmacy, Belagavi
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above 18yrs of both the gender. Patients with a histological / pathological confirmation of cancer diagnosis. Patients undergoing chemotherapy.

Exclusion criteria

Exclusion criteria: Vulnerable patients (pregnant women, lactating women, disabled people). Patients who are not on chemotherapy. Patients who are not willing to participate in research.

Design outcomes

Primary

MeasureTime frame
Evaluate the effectiveness of preventive strategies for chemotherapy induced nausea vomiting. Decreased incidence and severity of chemotherapy induced nausea and vomiting and Clinical pharmacist interventional tools to reduce CINV-related complications and improved patient quality of life.Timepoint: 1 week, 2 weeks and 3 weeks—

Secondary

MeasureTime frame
NILTimepoint: NIL—

Countries

India

Contacts

Public ContactHarshvardhan Patil

KLE College of Pharmacy, Belagavi

manjulag@klepharm.edu7204551475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026